OBJECTIVE: The goal of this study was to develop and validate a short form of the Childhood Trauma Questionnaire (the CTQ-SF) as a screening measure for maltreatment histories in both clinical and nonreferred groups. METHOD: Exploratory and confirmatory factor analyses of the 70 original CTQ items were used to create a 28-item version of the scale (25 clinical items and three validity items) and test the measurement invariance of the 25 clinical items across four samples: 378 adult substance abusing patients from New York City, 396 adolescent psychiatric inpatients, 625 substance abusing individuals from southwest Texas, and 579 individuals from a normative community sample (combined N=1978). RESULTS: Results showed that the CTQ-SF's items held essentially the same meaning across all four samples (i.e., measurement invariance). Moreover, the scale demonstrated good criterion-related validity in a subsample of adolescents on whom corroborative data were available. CONCLUSIONS: These findings support the viability of the CTQ-SF across diverse clinical and nonreferred populations.
OBJECTIVE: The goal of this study was to develop and validate a short form of the Childhood Trauma Questionnaire (the CTQ-SF) as a screening measure for maltreatment histories in both clinical and nonreferred groups. METHOD: Exploratory and confirmatory factor analyses of the 70 original CTQ items were used to create a 28-item version of the scale (25 clinical items and three validity items) and test the measurement invariance of the 25 clinical items across four samples: 378 adult substance abusing patients from New York City, 396 adolescent psychiatric inpatients, 625 substance abusing individuals from southwest Texas, and 579 individuals from a normative community sample (combined N=1978). RESULTS: Results showed that the CTQ-SF's items held essentially the same meaning across all four samples (i.e., measurement invariance). Moreover, the scale demonstrated good criterion-related validity in a subsample of adolescents on whom corroborative data were available. CONCLUSIONS: These findings support the viability of the CTQ-SF across diverse clinical and nonreferred populations.
Authors: M Mercedes Perez-Rodriguez; Shauna Weinstein; Antonia S New; Laura Bevilacqua; Qiaoping Yuan; Zhifeng Zhou; Colin Hodgkinson; Marianne Goodman; Harold W Koenigsberg; David Goldman; Larry J Siever Journal: J Psychiatr Res Date: 2010-05-06 Impact factor: 4.791
Authors: Erin E Edmiston; Fei Wang; Carolyn M Mazure; Joanne Guiney; Rajita Sinha; Linda C Mayes; Hilary P Blumberg Journal: Arch Pediatr Adolesc Med Date: 2011-12
Authors: Rebecca S Hock; Cyralene P Bryce; Deborah P Waber; Sarah McCuskee; Garrett M Fitzmaurice; David C Henderson; Janina R Galler Journal: Vulnerable Child Youth Stud Date: 2017-09-06
Authors: Jeff R Temple; Hye Jeong Choi; Tyson Reuter; David Wolfe; Catherine A Taylor; Sheri Madigan; Lauren E Scott Journal: J Pediatr Date: 2017-12-05 Impact factor: 4.406
Authors: Christopher D King; Sarah B Hill; Jonathan D Wolff; Cara E Bigony; Sherry Winternitz; Kerry J Ressler; Milissa L Kaufman; Lauren A M Lebois Journal: Psychiatry Res Date: 2020-07-17 Impact factor: 3.222
Authors: Timothy B Meier; Wayne C Drevets; T Kent Teague; Brent E Wurfel; Sven C Mueller; Jerzy Bodurka; Robert Dantzer; Jonathan Savitz Journal: Brain Behav Immun Date: 2017-09-01 Impact factor: 7.217
Authors: Anne N Banducci; Jennifer Dahne; Jessica F Magidson; Kevin Chen; Stacey B Daughters; C W Lejuez Journal: Addict Behav Date: 2012-12-24 Impact factor: 3.913
Authors: Sinan Guloksuz; Lotta-Katrin Pries; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; EylemŞahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşog Lu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os Journal: World Psychiatry Date: 2019-06 Impact factor: 49.548
Authors: U Dannlowski; H J Grabe; K Wittfeld; J Klaus; C Konrad; D Grotegerd; R Redlich; T Suslow; N Opel; P Ohrmann; J Bauer; P Zwanzger; I Laeger; C Hohoff; V Arolt; W Heindel; M Deppe; K Domschke; K Hegenscheid; H Völzke; D Stacey; H Meyer Zu Schwabedissen; H Kugel; B T Baune Journal: Mol Psychiatry Date: 2014-04-29 Impact factor: 15.992